Pharma IQ | 09/05/2010
Reto Ossola, Group Leader for Biomarket Research at Biognosys, joins Helen Winsor from Pharma IQ, to discuss phase I clinical development. He outlines where he sees the main challenges in biomarker development at the moment and discusses some key ways to address the cost-efficiency pressures. The interview also takes a look at partnerships - Ossola offers some best practice tips on assessing and working with a CRO, together with a summary of the main challenges in selecting partners and ens...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More